Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Patients and data tracking

- PMLiVE

Words aside, ESG’s role is non-negotiable

By Arabella Moore

Unleashing Creativity in Virtual Pharma Engagements

Think outside the box with virtual engagements! Discover how creative asynchronous touchpoints can revolutionize your interactions. Explore everything from OLAs to treatment pathway profiling via a pharma-compliant virtual platform.

Impetus Digital

- PMLiVE

AstraZeneca’s Truqap plus Faslodex granted EC approval to treat advanced breast cancer

More than 550,000 new cases of breast cancer were diagnosed in Europe in 2022

- PMLiVE

Sanofi and Belharra Therapeutics enter $700m immunological disease collaboration

The partnership will utilise Belharra’s platform to identify and advance small molecules against immunology targets

- PMLiVE

Researchers develop AI blood test to predict Parkinson’s seven years before symptom onset

The neurodegenerative condition currently affects nearly ten million people worldwide

- PMLiVE

WHO publishes latest report on development of antibacterial agents worldwide

AMR is designated as one of the top ten global public health threats facing humanity

- PMLiVE

Key sustainability trends and challenges facing pharmaceutical companies

Looking at the opportunities and benefits of implementing sustainable procurement practices

- PMLiVE

Roche and Ascidian enter neurological disease partnership worth over $1.8bn

More than three billion people worldwide were living with a neurological condition in 2021

- PMLiVE

Merck’s adult-specific pneumococcal vaccine Capvaxive granted FDA approval

The vaccine is designed to protect against the strains responsible for the majority of adult invasive pneumococcal disease

- PMLiVE

AbbVie’s IL-23 inhibitor Skyrizi approved by FDA to treat ulcerative colitis in adults

The inflammatory bowel disease affects more than one million people in the US

- PMLiVE

Johnson & Johnson’s investigational nipocalimab shows promise in Sjögren’s disease

The chronic autoimmune disease is estimated to affect four million people worldwide

- PMLiVE

Sustainability and environmentalism in the pharmaceutical industry

In this Q&A, Claire Knapp, CEO of Havas Lynx, talks to PME about why the path to sustainability in healthcare is fraught with significant challenges and highlights the need for...

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links